SCM
EVGN icon

Silverarc Capital Management’s Evogene EVGN Stock Holding History

Silverarc Capital Management’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-307,974
Closed -$945K – 73
2024
Q3 		$945K Hold
307,974
– – 0.21% 55
2024
Q2 		$2M Sell
307,974
-576
-0.2% -$4.02K 0.47% 51
2024
Q1 		$2.31M Sell
308,550
-1,450
-0.5% -$12.1K 0.64% 46
2023
Q4 		$2.6M Hold
310,000
– – 0.78% 43
2023
Q3 		$1.82M Buy
310,000
+300,000
+3,000% +$2.63M 0.55% 49
2023
Q2 		$107K Buy
+10,000
New +$67.6K 0.03% 78
2023
Q1 		– Sell
-15,036
Closed -$105K – 88
2022
Q4 		$105K Sell
15,036
-1,715
-10% -$12.1K 0.03% 86
2022
Q3 		$139K Sell
16,751
-3,481
-17% -$33.6K 0.05% 75
2022
Q2 		$156K Sell
20,232
-9,343
-32% -$91.3K 0.05% 67
2022
Q1 		$384 Buy
29,575
+269
+0.9% +$3.63K 0.16% 59
2021
Q4 		$481K Buy
29,306
+4,473
+18% +$101K 0.19% 66
2021
Q3 		$656K Sell
24,833
-11,292
-31% -$329K 0.37% 62
2021
Q2 		$1.24K Buy
36,125
+1,125
+3% +$44.1K 0.55% 64
2021
Q1 		$1.76M Sell
35,000
-25,000
-42% -$1.55M 0.96% 39
2020
Q4 		$2.82M Buy
+60,000
New +$2.12M 1.64% 23

Other funds holding EVGN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Silverarc Capital Management's EVGN Position: Q4 2024 in Review

Silverarc Capital Management sold out of Evogene (EVGN) in Q4 2024, closing a stake of 307,974 shares — an estimated $945K sold.

Silverarc Capital Management first reported a position in EVGN in Q4 2020 and held it in 15 quarters. The position peaked at $2.82M in Q4 2020. 15 funds tracked by Wall St. Rank hold EVGN as of Q4 2024.

  • Silverarc Capital Management reported no remaining Evogene position as of Q4 2024 after selling out during the quarter.
  • Silverarc Capital Management sold 307,974 Evogene shares in Q4 2024, an estimated $945K.
  • Silverarc Capital Management first reported a position in Evogene in Q4 2020 and held it in 15 quarters.
  • Silverarc Capital Management's Evogene position peaked at $2.82M in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Evogene as of Q4 2024.

Based on Silverarc Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.